EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Plasma adiponectin and biomarker‐confirmed Alzheimer's disease in a tertiary memory clinic

Louise Sindzingre iD, Elodie Bouaziz-Amar, François Mouton-Liger, Emmanuel Cognat, Julien Dumurgier, Karl Götze, Matthieu Martinet, Agathe Vrillon, Claire Paquet, Matthieu Lilamand

Journal of Neuroendocrinology · 2025

DOI: 10.1111/jne.13493 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Neuroendocrinology, 2025. Verfasst von Louise Sindzingre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, UMRS 1144, INSERM, Paris, France. Hauptthemen laut MEDLINE: Adiponectin, Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is associated with early metabolic dysfunction and adiponectin, which may play a pathophysiological role. Adiponectin is implicated in the regulation of energy homeostasis, carbohydrate, and lipid metabolism, as well as in inflammation modulation. The aim of this study was to study whether plasma adiponectin levels were different between patients with AD confirmed by biomarkers and neurological control subjects. We performed a monocentric, retrospective, cross‐sectional, observational study in AD patients and neurological controls recruited from daily clinical practice in a tertiary memory clinic. Plasma adiponectin levels were measured using a chemiluminescent enzyme immunoassay. We analyzed the relationship between adiponectin and AD using linear regression models including age, gender, and BMI. We also described the distribution of adiponectin concentrations, across age, and gender categories. Two hundred and six patients (142 AD patients and 64 neurological controls) were included, with mean age = 68.8 ± 10.0 years, and 56% were women. Higher adiponectin concentrations were observed in females and in older adults. Plasma adiponectin levels were significantly higher in AD patients (mean = 6.45 ± 3.42 μg/mL) than neurological controls (4.85 ± 3.54 μg/mL) ( p < .001). This association was mediated by age, gender, and BMI, which were significantly and independently associated with plasma adiponectin levels ( p < .01 for each), while adiponectin was no longer associated with AD in multivariate models. Patients with AD showed higher adiponectin levels, but this association was driven by older age, female gender, and lower BMI in the AD group. Further studies are needed to better characterize the hormonal signature of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdiponectinAlzheimer DiseaseHumansFemaleMaleAgedBiomarkersMiddle AgedCross-Sectional StudiesRetrospective StudiesAged, 80 and overTertiary Care Centers

Stichwörter der Autor:innen

Alzheimer's diseaseadipokinesadiponectinadipose tissuemetabolism

Substanzen

AdiponectinBiomarkersADIPOQ protein, human

Autor:innen und Institutionen

  • Université Paris Cité, UMRS 1144, INSERM, Paris, France.
  • Centre de Neurologie Cognitive, AP-HP.Nord, Site Lariboisière Fernand-Widal, Paris, France.
  • Service de Biochimie, AP-HP.Nord, Site Lariboisière Fernand-Widal, Paris, France.
  • Département de Gériatrie, AP-HP.Nord, Site Bichat, Paris, France.
  • Service de Gériatrie, AP-HP.Nord, Site Lariboisière Fernand-Widal, Paris, France.

ORCID-Profile: Louise Sindzingre

Zitieren

APA

Sindzingre, L., Bouaziz-Amar, E., Mouton-Liger, F., Cognat, E., Dumurgier, J., Götze, K., Martinet, M., Vrillon, A., Paquet, C., & Lilamand, M. (2025). Plasma adiponectin and biomarker‐confirmed Alzheimer's disease in a tertiary memory clinic. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.13493

Vancouver

Sindzingre L, Bouaziz-Amar E, Mouton-Liger F, Cognat E, Dumurgier J, Götze K, et al. Plasma adiponectin and biomarker‐confirmed Alzheimer's disease in a tertiary memory clinic. Journal of Neuroendocrinology. 2025. doi:10.1111/jne.13493

BibTeX
@article{Sindzingre2025,
  author = {Sindzingre, Louise and Bouaziz-Amar, Elodie and Mouton-Liger, François and Cognat, Emmanuel and Dumurgier, Julien and Götze, Karl and Martinet, Matthieu and Vrillon, Agathe and Paquet, Claire and Lilamand, Matthieu},
  title = {Plasma adiponectin and biomarker‐confirmed Alzheimer's disease in a tertiary memory clinic},
  journal = {Journal of Neuroendocrinology},
  year = {2025},
  doi = {10.1111/jne.13493}
}
Kostenlos starten →